Mirkka Sarparanta

2.0k total citations
53 papers, 1.5k citations indexed

About

Mirkka Sarparanta is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Materials Chemistry. According to data from OpenAlex, Mirkka Sarparanta has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Materials Chemistry. Recurrent topics in Mirkka Sarparanta's work include Radiopharmaceutical Chemistry and Applications (16 papers), Silicon Nanostructures and Photoluminescence (9 papers) and Click Chemistry and Applications (8 papers). Mirkka Sarparanta is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (16 papers), Silicon Nanostructures and Photoluminescence (9 papers) and Click Chemistry and Applications (8 papers). Mirkka Sarparanta collaborates with scholars based in Finland, United States and Netherlands. Mirkka Sarparanta's co-authors include Anu J. Airaksinen, Hélder A. Santos, Ermei Mäkilä, Jarno Salonen, Jouni Hirvonen, Timo Laaksonen, Luís M. Bimbo, Outi Keinänen, Vesa‐Pekka Lehto and Surachet Imlimthan and has published in prestigious journals such as Advanced Materials, ACS Nano and PLoS ONE.

In The Last Decade

Mirkka Sarparanta

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirkka Sarparanta Finland 21 634 570 474 371 290 53 1.5k
Einar Sulheim Norway 17 1.2k 1.9× 467 0.8× 603 1.3× 834 2.2× 137 0.5× 26 2.0k
Yeong Mi Lee South Korea 19 765 1.2× 265 0.5× 553 1.2× 616 1.7× 54 0.2× 30 1.6k
Beata Chertok United States 16 996 1.6× 385 0.7× 398 0.8× 1.1k 2.8× 88 0.3× 19 1.8k
Xuehua Ma China 23 1.1k 1.8× 743 1.3× 474 1.0× 622 1.7× 114 0.4× 59 1.9k
Liangran Guo China 21 1.2k 1.8× 619 1.1× 982 2.1× 998 2.7× 125 0.4× 27 2.5k
Veronika Mamaeva Finland 12 634 1.0× 522 0.9× 522 1.1× 589 1.6× 71 0.2× 15 1.6k
Nicholas Thomas Blum China 26 1.6k 2.5× 843 1.5× 416 0.9× 570 1.5× 79 0.3× 33 2.1k
Xingya Jiang United States 17 829 1.3× 1.0k 1.8× 803 1.7× 512 1.4× 67 0.2× 28 2.4k
Wenjun Le China 17 839 1.3× 461 0.8× 482 1.0× 440 1.2× 60 0.2× 40 1.5k
Ao Li China 22 899 1.4× 642 1.1× 292 0.6× 461 1.2× 268 0.9× 82 1.6k

Countries citing papers authored by Mirkka Sarparanta

Since Specialization
Citations

This map shows the geographic impact of Mirkka Sarparanta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirkka Sarparanta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirkka Sarparanta more than expected).

Fields of papers citing papers by Mirkka Sarparanta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirkka Sarparanta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirkka Sarparanta. The network helps show where Mirkka Sarparanta may publish in the future.

Co-authorship network of co-authors of Mirkka Sarparanta

This figure shows the co-authorship network connecting the top 25 collaborators of Mirkka Sarparanta. A scholar is included among the top collaborators of Mirkka Sarparanta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirkka Sarparanta. Mirkka Sarparanta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Utsunomiya, Satoshi, Jessica M. Walker, Julia E. Parker, et al.. (2025). Chemical alteration of UO2 micro-particles in model lung systems. Journal of Hazardous Materials. 497. 139670–139670.
2.
Imlimthan, Surachet, Heidi Liljenbäck, Kristiina M. Huttunen, et al.. (2025). Biological evaluation of a glucose‐based boron carrier as a potential agent for boron neutron capture therapy. International Journal of Cancer. 157(11). 2374–2384. 1 indexed citations
3.
Imlimthan, Surachet, Heidi Harjunpää, Susanne Κ. Wiedmer, et al.. (2025). Aluminum-[18F]fluoride radiolabeling of triarylphosphines for cell labeling via the perfluoroaryl azide Staudinger ligation. EJNMMI Radiopharmacy and Chemistry. 10(1). 79–79.
4.
Kohtala, Samuel, et al.. (2024). Nitrous oxide induces hypothermia and TrkB activation: Maintenance of body temperature abolishes antidepressant-like effects in mice. Neuropharmacology. 261. 110172–110172. 1 indexed citations
6.
Wang, Shiqi, et al.. (2024). Quantitative analysis of electroporation-mediated intracellular delivery via bioorthogonal luminescent reaction. Communications Chemistry. 7(1). 181–181. 2 indexed citations
7.
Horie, Kenji, Mami Takehara, Shinya Yamasaki, et al.. (2024). “Invisible” radioactive cesium atoms revealed: Pollucite inclusion in cesium-rich microparticles (CsMPs) from the Fukushima Daiichi Nuclear Power Plant. Journal of Hazardous Materials. 470. 134104–134104. 1 indexed citations
8.
Vugts, Daniëlle J., Surachet Imlimthan, Mirkka Sarparanta, et al.. (2022). Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [89Zr]Zr-DFO-PEG5-Tz. Bioconjugate Chemistry. 33(5). 956–968. 11 indexed citations
9.
Imlimthan, Surachet, Helena E. Virtanen, Heidi Liljenbäck, et al.. (2022). Development of [18F]AmBF3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [18F]AmBF3-PEG7-Tyr3-Octreotide in an AR42J Pancreatic Carcinoma Model. Bioconjugate Chemistry. 33(7). 1393–1404. 17 indexed citations
10.
Imlimthan, Surachet, Outi Keinänen, Wenzhong Zhang, et al.. (2021). A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma. Small. 17(18). e2007705–e2007705. 38 indexed citations
11.
Imlimthan, Surachet, et al.. (2020). Evaluation of Organo [18F]Fluorosilicon Tetrazine as a Prosthetic Group for the Synthesis of PET Radiotracers. Molecules. 25(5). 1208–1208. 10 indexed citations
13.
14.
Sarparanta, Mirkka, Jacob Pourat, Kathryn E. Carnazza, et al.. (2019). Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer. Nuclear Medicine and Biology. 80-81. 1–12. 15 indexed citations
15.
Keinänen, Outi, Ermei Mäkilä, Helena E. Virtanen, et al.. (2017). Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles. ACS Omega. 2(1). 62–69. 47 indexed citations
16.
Lakkisto, Päivi, et al.. (2017). Carbon monoxide releasing molecule improves structural and functional cardiac recovery after myocardial injury. European Journal of Pharmacology. 818. 57–66. 21 indexed citations
17.
Demoin, Dustin Wayne, Linden C. Wyatt, Kimberly J. Edwards, et al.. (2016). PET Imaging of Extracellular pH in Tumors with64Cu- and18F-Labeled pHLIP Peptides: A Structure–Activity Optimization Study. Bioconjugate Chemistry. 27(9). 2014–2023. 48 indexed citations
18.
Kallionpää, Roope A., Susanne Bäck, Mirkka Sarparanta, et al.. (2014). Synthesis and biological evaluation of novel 123I-labeled 4-(4-iodophenyl)butanoyl-l-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo. European Journal of Medicinal Chemistry. 79. 436–445. 2 indexed citations
19.
Bimbo, Luís M., Mirkka Sarparanta, Ermei Mäkilä, et al.. (2011). Mesoporous silicon particles as biocompatible drug delivery agents. Data Archiving and Networked Services (DANS). 44. 1 indexed citations
20.
Hakkarainen, Tanja, Maria Rajecki, Mirkka Sarparanta, et al.. (2009). Targeted Radiotherapy for Prostate Cancer with an Oncolytic Adenovirus Coding for Human Sodium Iodide Symporter. Clinical Cancer Research. 15(17). 5396–5403. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026